e-SPACE Heart Failure 2022
Published: 19 October 2022
-
Views:
17543
-
Likes:
7
-
Views:
17543
-
Likes:
7
-
Up Next
-
33m 53s
-
34m 37s
-
1h 2m 37sPart 1 | Session 11 Plenary Session 5: Managing side effects of HF drugs
-
37m 5sPart 1 | Session 12 Meet the expert: Sex differences in advanced heart failure
-
1h 1m 4sPart 1 | Session 13 Plenary Session 6: How to manage the obese patient with HF
-
1h 2m 46sPart 2 | Session 1 Plenary Session 7: New technologies to manage your patients
-
33m 44s
-
1h 4m 11sPart 2 | Session 3 Plenary Session 8: New technologies to treat your patients
-
1h 9sPart 2 | Session 4 Plenary Session 9: Comparing European and US recent guidelines
-
46m 45s
-
1h 1m 38s
-
30m 11s
-
1h 1m 4sPart 2 | Session 8 Plenary Session 11: Managing the HF patient with valvular heart disease
-
31m 36s
-
1h 1m 28sPart 2 | Session 10 Plenary Session 12: Managing the patient with worsening and advanced HF
-
1h 1m 14sPart 1 | Session 1 Plenary Session 1: Implementing the 4 foundational therapies in clinical practice John J Atherton, Piotr Ponikowski, Mark Petrie, Gianluigi Savarese, Kieran Docherty
-
32m 48sPart 1 | Session 2 Meet the expert: Emerging evidence across the spectrum of heart failure: new insights from the deliver trial (Supported by an educational grant from AstraZeneca) John JV McMurray, Rudolf A. de Boer
-
1h 22sPart 1 | Session 3 Plenary Session 2: Managing your HF patients with comorbidities (part 1) Yuhui Zhang, David Sim, Giuseppe Rosano, Vijay Chopra, Béla Merkely, A John Camm
-
36m 21sPart 1 | Session 4 Meet the expert: SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Maurizio Volterrani, Anja Sandek
-
1h 1m 19sPart 1 | Session 6 Plenary Session 3: Using SGLT2 in your patients: practical considerations Philippe Gabriel Steg, Shelley Zieroth, Milton Packer, Muthiah Vaduganathan, Cecilia Bahit , Subodh Verma
-
41m 26sPart 1 | Session 7 Satellite Symposium: SGLT2 inhibition as foundational heart failure therapy: have we changed our practices? (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Andrew JS Coats, Shelley Zieroth, Stefan Anker, Daniela Tomasoni, Clara Saldarriaga
Overview
e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.
Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.
For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
![Sponsor](https://assets.radcliffecardiology.com/s3fs-public/video-series/2022-10/espace%20Sponsors.png?VersionId=tPYLvbGfakDnsZ3Z7H1xqmtPtBqNs9dF)
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day 1
Part 2
Day 2
Faculty Biographies
![Giuseppe Galati](https://assets.radcliffecardiology.com/s3fs-public/author/2020-12/Galati.jpg)
Giuseppe Galati
Consultant Cardiologist Heart Failure and Cardiomyopathies
Dr Giuseppe Galati is a Senior Consultant Cardiologist – Heart Failure & Cardiomyopathies Specialist at IRCCS Multimedica, Cardiovascular Scientific Institute, in Sesto San Giovanni, Milan, Italy.
After graduating in Medicine and Surgery and specialising in Cardiovascular Diseases both at the University of Bologna (both cum laude), he achieved a II Level Master of Competence in Heart Failure at the University of Florence (co-organised by the Italian Association of Hospital Cardiologists), and a Certificate of Competence in Heart Failure given by the Heart Failure Association of the European Society of Cardiology.
Moreover, he took a 2-year Postgraduate Course in Heart Failure London, achieving the Certificate in Heart Failure Management and became a Fellow of the Heart Failure Association of the ESC.
Over the last 15 years, Dr Galati gained relevant expertise in all aspects of Heart Failure: from diagnosis to physiopathology, biomarkers,…
![Altamash Y Shaikh](https://assets.radcliffecardiology.com/s3fs-public/author/2022-10/Altamash%20Y.%20Shaikh.png?VersionId=7cvATQGfGKFAvFDNGJYtePeoyHm3zk5m)
Altamash Y Shaikh
Consultant Endocrinologist
Dr Altamash Y. Shaikh is a Consultant Endocrinologist, Diabetologist and Metabolic Physician based at Saifee Hospital, Mumbai, IN.
![Ewa Jankowska](https://assets.radcliffecardiology.com/s3fs-public/author/2021-09/Jankowska%2C%20Ewa%20Anita.png)
Ewa Jankowska
Prof Ewa Jankowska is Professor of Medicine and Head of Laboratory of Applied Research on Cardiovascular System at the Department of Heart Diseases, Wroclaw Medical University, Poland. Her clinical and research interests include the role of peripheral mechanisms in the progression of heart failure, co-morbidities in heart failure, and experimental model of tachycardia-induced cardiomyopathy.
Prof Jankowska is an Editorial Board member of Cardiac Failure Review.
![George L Bakris](https://assets.radcliffecardiology.com/s3fs-public/author/2023-12/A48E763F8B.jpeg?VersionId=hJ5vDUCDUgpfekyPDvr3qAHYuDFGEiwd)
George L Bakris
President Elect
Dr George L. Bakris, MD, is a distinguished member of the National Kidney Foundation's Board of Directors. As the Professor of Medicine and Director of the Comprehensive Hypertension Center at the University of Chicago Medicine, he brings a wealth of expertise to the forefront of medical education.
Previously serving as the Vice-Chairman of Preventive Medicine and Director of the Rush University Hypertension Center in Chicago, Dr Bakris has made significant contributions to the understanding of hypertension, diabetic kidney disease, and nephropathy progression. With a prolific publication record boasting over 700 articles and book chapters, his work has significantly impacted the landscape of cardiovascular research.
Dr Bakris has played a pivotal role in shaping national guidelines, serving on committees such as the Joint National Committee (JNC) Writing Groups VI & 7, the JNC 7 executive committee, the American Diabetes Association Clinical Practice Guideline…
![Stephan Von Haehling](https://assets.radcliffecardiology.com/s3fs-public/author/2023-03/von%20Haehling_Stephan.jpg?VersionId=EFCawP6DxK1xIx57W1K6LPb8Wm89UZ6o)
Stephan Von Haehling
Professor of Cardiology and Consultant Cardiologist
Prof Stephan von Haehling is a Professor of Cardiology and Consultant Cardiologist at University Medicine Göttingen, Göttingen, DE.
His PhD was awarded by Imperial College, London, UK after he completed studies on inflammatory mechanisms of heart failure at the National Heart and Lung Institute in London.
Prof von Haehling is a Fellow of the European Society of Cardiology and of the Heart Failure Association of the ESC. His research interests include the pathophysiology and the co-morbidities of heart failure, with particular focus on muscle wasting, biomarkers, and novel treatments.
![Javed Butler](https://assets.radcliffecardiology.com/s3fs-public/author/2021-05/javedbutler.png)
Javed Butler
Professor of Medicine
Dr Javed Butler is President, Baylor Scott and White Research Institute, Senior Vice President for the Baylor Scott and White Health and Professor of Medicine at the University of Mississippi, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure.
He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.
Prof Butler has authored more than 900 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals and has been cited numerous times in America’s Best Doctors list.